Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01699425
Other study ID # AJA201205
Secondary ID
Status Completed
Phase N/A
First received September 22, 2012
Last updated March 27, 2017
Start date March 2013
Est. completion date May 2016

Study information

Verified date March 2017
Source Hospital Universitari Vall d'Hebron Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The transobturator tension-free vaginal tape (TOT) procedure has demonstrated high cure rates comparable to those obtained by retropubic suburethral tape, becoming the first line treatment for stress urinary incontinence (SUI) in many cases. The TOT procedure is not exempt from complications such as bleeding, bladder injuries and pain in the thigh/groin. In addition it is commonly performed under general or regional anesthesia1-3. The single-incision mini-slings (SIMS) were developed to reduce the risk of complications by avoiding the blind passage of the trocars through the obturator space. In addition, the use of SIMS could enable surgeons to perform the procedure truly under local anesthesia.

Different devices for SIMS procedure are available. However, the evidence about their efficacy is controversial4-7. The main limitation of these devices could be the predetermined length of the mesh and the weakness on its fixation. The design of the SIMS Ajust® allows adjusting the length of the sling to each individual woman and provides a robust fixation into the obturator membrane. Recent prospective studies on the efficacy and safety of the sling Ajust® have obtained promising results8,9. Even so, the NICE guidelines advise to use SIMS in the context of research studies10.

The objective of this study is to establish if the effectiveness of the SIMS Ajust® is non-inferior to that of a standard TOT, as well as to compare the comorbidity of both procedures. Owing to the new appearance and fast evolution of these procedures, randomized comparative studies with SIMS are required in order to determine its place in the treatment of SUI.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Stress urinary incontinence with urethral hypermobility.

Exclusion Criteria:

- Incapacity to understand the information or give their consent.

- Previous anti-incontinence surgery with slings.

- Urethral hypomobility (Q-tip test <30º).

- Low pressure urethra (MUCP < 20cmH2O).

- Detrusor overactivity.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ajust sling

Classical transobturator sling
Control group

Locations

Country Name City State
Spain Hospital Universitari Vall d'Hebron Barcelona
Spain Hospital Universitari de Girona Dr. Josep Trueta Girona
Spain Hospital Universitari de Bellvitge Hospitalet Barcelona
Spain Hospital de Palamós Palamós Girona
Spain Hospital de Viladecans Viladecans Barcelona

Sponsors (5)

Lead Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute Hospital de Palamós, Hospital de Viladecans, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in the Maximal Urethral Closure Pressure. Comparison of the changes in the Maximal Urethral Closure Pressure (cmH2O) measured preoperatively and 1 year after surgery. One year after surgery.
Primary Comparison of the cure rates between the single incision sling Ajust and classical transobturator tapes. Percentage of patients who are regarded as cured or improved based on the following criteria:
Improvement on the International consultation on Incontinence Urinary Questionnaire-Short Form 1 year after the surgery.
Negative Cough Stress test 1 year after surgery.
Up to one year
Secondary Number of participants with adverse events Comparison of the intra- and postoperative complications between procedures 0, 1, 6 and 12 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05534269 - Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy Phase 2
Completed NCT02023502 - Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study
Completed NCT01848938 - Treatment of Stress Urinary Incontinence Via Smartphone N/A
Completed NCT02418299 - Er:YAG Laser Treatment for Female Stress and Mixed Urinary Incontinence (IncontiLase) N/A
Completed NCT01094353 - A Comparative Study Minisling Versus Transobturator (TOT)Sling Phase 4
Completed NCT00910338 - Efficacy and Safety of Extracorporeal Biofeedback N/A
Completed NCT01290796 - Clinical Evaluation of Ajust™ in Stress Urinary Incontinence N/A
Recruiting NCT04131387 - The Safety and Efficacy of Micro-energy Ultrasound Therapy in the Treatment of Female Stress Urinary Incontinence N/A
Not yet recruiting NCT02981654 - Safety and Efficacy of Carbone Dioxide (CO2) Laser System in Treatment of Female Stress Urinary Incontinence. N/A
Completed NCT01032265 - Web-based Management of Female Stress Urinary Incontinence N/A